MoneyWorks4Me

The sales surged to Rs. 1863.84 millions, up 29.84% for the March 2023 quarter as against Rs. 1435.44 millions during the corresponding quarter previous year.Good  Net Profit growth of 27.63% reported above the corresponding previous quarter figure of Rs. 212.80 millions to Rs. 271.59 millioins.The company reported a good operating profit of 406.44 millions compared to 259.63 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1863.84 1435.44 29.84 6167.34 5201.35 18.57 6167.34 5201.35 18.57
Other Income -1.74 1.76 -198.86 43.20 27.62 56.41 43.20 27.62 56.41
PBIDT 406.44 259.63 56.55 1269.82 1079.38 17.64 1269.82 1079.38 17.64
Interest 5.94 5.89 0.85 24.14 64.07 -62.32 24.14 64.07 -62.32
PBDT 400.50 253.74 57.84 1245.68 1015.31 22.69 1245.68 1015.31 22.69
Depreciation 34.27 31.12 10.12 123.42 100.80 22.44 123.42 100.80 22.44
PBT 366.23 222.62 64.51 1122.26 914.51 22.72 1122.26 914.51 22.72
TAX 94.64 9.82 863.75 288.82 195.04 48.08 288.82 195.04 48.08
Deferred Tax 5.96 0.47 1168.09 25.05 27.83 -9.99 25.05 27.83 -9.99
PAT 271.59 212.80 27.63 833.44 719.47 15.84 833.44 719.47 15.84
Equity 364.37 364.37 0.00 364.37 364.37 0.00 364.37 364.37 0.00
PBIDTM(%) 21.81 18.09 20.56 20.59 20.75 -0.78 20.59 20.75 -0.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..